Related Experiment Video
Updated: Jun 22, 2026
05:28
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
CRP/CD11b ratio: a novel parameter for detecting gram-positive sepsis
Jari Nuutila1, Päivi Jalava-Karvinen, Ulla Hohenthal
1Department of Biochemistry, University of Turku, Vatselankatu 2, 20014 Turku, Finland. jarnuu@utu.fi
Human Immunology
|June 2, 2009
Summary
A novel CRP/CD11b ratio test can help distinguish gram-positive from gram-negative bacterial infections in sepsis patients. This biomarker aids clinicians in selecting appropriate antibiotic treatments for severe infections.
Area of Science:
- Medical Microbiology
- Clinical Diagnostics
- Immunology
Background:
- Distinguishing gram-positive (gram(+)) from gram-negative (gram(-)) bacterial infections is crucial for effective sepsis treatment.
- Current diagnostic methods may not always provide rapid differentiation, delaying targeted antibiotic therapy.
Purpose of the Study:
- To develop a method for differentiating gram(+) from gram(-) bacterial infections in patients with sepsis.
- To identify a novel biomarker that assists clinicians in choosing appropriate antibiotic regimens.
Main Methods:
- A prospective clinical study involving patients with bacterial infections.
- Measurement of neutrophil CD11b expression and serum C-reactive protein (CRP) levels.
- Development of the CRP/CD11b ratio as a diagnostic marker.
Main Results:
- Neutrophil CD11b expression was significantly higher in gram(-) infections compared to gram(+) infections.
- Serum CRP levels were significantly higher in gram(+) infections than in gram(-) infections.
- The CRP/CD11b ratio demonstrated 76% sensitivity and 80% specificity for detecting gram(+) sepsis.
Conclusions:
- The CRP/CD11b ratio is a promising marker for identifying gram(+) sepsis.
- Combining neutrophil CD11b and serum CRP levels can aid in the detection of gram(+) sepsis.
- This ratio test may assist physicians in optimizing antibiotic selection for severe bacterial infections.
